• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

January 29, 2025

Mitochondrial Dysfunction Present in Visceral Adipose Tissue in Patients With Obesity-Related MASH

Author(s):

Gillian McGovern, Associate Editor

Key Takeaways

  • Mitochondrial dysfunction in VAT is associated with MASH, affecting lipid metabolism and liver health.
  • Weight loss shifts oxylipin profiles towards proinflammatory species, despite reduced fatty acids.
  • Systems biology approach identified pathways of inflammation, mitochondrial dysfunction, and lipotoxicity in MASH.
  • Plasma lipidomics demonstrated high diagnostic accuracy for MASH, suggesting circulating lipids as potential non-invasive biomarkers.
SHOW MORE

The authors note that this may cause disruptions in the metabolic stability of lipid processing and storage, impacting the liver and accelerating damaging adaptative responses.

Research published in eBioMedicine showed that mitochondrial dysfunction is also present in visceral adipose tissue (VAT) in patients who have metabolic dysfunction-associated steatohepatitis (MASH). This may result in a disruption within the metabolic equilibrium of lipid processing and storage, therefore, impacting the liver and accelerating harmful adaptive responses in patients with MASH.1

Man with hepatitis MASH -- Image credit: Orawan | stock.adobe.com

Image credit: Orawan | stock.adobe.com

The storage of fat in humans is closely associated with the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) and the more severe form, MASH. Therefore, adipose tissue metabolic homeostasis could be key in both the onset and progression of MASH. For this case-control, observational study1, the investigators enrolled 100 patients undergoing bariatric surgery who were enrolled from a prior clinical trial (NCT05554224)2, which aimed to analyze samples provided by patients with obesity-associated MASLD and MASH at the multi-omics level.1

In the prior study3, which was published in Clinical Nutrition, in which the main aim was to assess the effectiveness of surgically induced weight loss in patients with diabetes- or obesity-related fatty liver disease, the investigators observed significantly elevated levels of circulating fatty acids and oxylipins in patients with severe obesity compared with their metabolically healthier overweight or obese counterparts.2,3 Prior to surgery, oxylipins originating from lipoxygenase activity—such as 12-HETE, 11-HDoHE, 14-HDoHE, and 12-HEPE—were prevalent; however, 1 year following laparoscopic sleeve gastrectomy, there was a complex shift in the oxylipin profile, which favored species from the cyclooxygenase pathway, such as proinflammatory prostanoids (eg, TXB2, PGE2, PGD2, and 12-HHTrE). This change, according to the authors, appeared to be linked to a reduction in adiposity, emphasizing lipid turnover’s influence in the development of severe obesity-related metabolic disorders.3

Despite the reduction in fatty acid levels that are associated with weight loss, the oxylipin profile shifts towards a prevalence of more proinflammatory species. These data indicate that mechanistic approaches to address severe obesity are needed, emphasizing the importance of closely monitoring the metabolic adaptations after weight loss.3

For the current study1, the investigators utilized a systems biology-based approach to analyze liver, abdominal subcutaneous adipose tissue (SAT), omental VAT, and blood. MASH was diagnosed through histologic assessment. Whole-slide image analysis, lipidomics, proteomics, and transcriptomics were performed on tissue samples, and lipidomics and proteomics profiles were determined on plasma samples.

The data demonstrated that liver transcriptomics, proteomics, and lipidomics revealed interconnected pathways associated with inflammation, mitochondrial dysfunction, and lipotoxicity in MASH. Additionally, paired adipose tissue biopsies were observed to have larger adipocyte areas in both fat depots in MASH. Further enrichment analyses of proteomics and lipidomics data confirmed the association of liver lesions with mitochondrial dysfunction in VAT. Plasma lipidomics also identified candidates with high diagnostic accuracy (AUC = 0.919, 95% CI 0.840–0.979) for effectively screening MASH.1

The findings suggest that circulating lipids serve as potential biomarkers for MASH, offering a non-invasive alternative for diagnosis in patients with severe obesity, the authors noted. By utilizing the systems biology approach, this study shows the multi-omics profiles of liver tissue and 2 distinct adipose tissue depots from patients with severe obesity, with and without MASH. Additionally, the minimization of confounding factors—including adipose tissue amount and distribution—can lead to significant differences in mitochondrial lipid metabolism in VAT.1

REFERENCES
1. Castañé H, Jiménez-Franco A, Hernández-Aguilera A, et al. Multi-omics profiling reveals altered mitochondrial metabolism in adipose tissue from patients with metabolic dysfunction-associated steatophepatitis. eBioMedicine. 2025;111:105532. doi:10.1016/j.ebiom.2024.105532
2. Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver Disease. ClinicalTrials.gov identifier: NCT05554224. Updated November 13, 2024. Accessed January 21, 2025. https://clinicaltrials.gov/study/NCT05554224
3. Jiménez-Franco A, Castañé H, Martínez-Navidad C, et al. Metabolic adaptations in severe obesity: Insights from circulating oxylipins before and after weight loss. Clin Nutr. 2024;43(1):246-258. doi:10.1016/j.clnu.2023.12.002

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Austin Texas | Image credit: Kevin Ruck - stock.adobe.com
Pharmacy Times OPC
Related Content
Advertisement
Visualization of pulmonary hypertension | Image Credit: © Thirawat - stock.adobe.com
June 30th 2025

Pulmonary Hypertension Associated With Increased Risk of Progression in Patients With Myeloproliferative Neoplasms

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Streptococcus Pneumoniae Bacteria
June 30th 2025

21-Valent Pneumococcal Conjugate Vaccine Exhibits Consistent Safety and Immunogenicity Across Manufacturing Lots

Luke Halpern, Assistant Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Bone marrow fibrosis visualization | Image Credit: © LimeSky - stock.adobe.com
June 30th 2025

INCB057643 in Combination with Ruxolitinib Improves Symptoms in Patients With Myelofibrosis

Alexandra Gerlach, Associate Editor
Woman with dry mouth -- Image credit: Rafael Ben-Ari | stock.adobe.com
June 28th 2025

Help Patients Prevent and Treat Dry Mouth

Jennifer Gershman, PharmD, CPh, PACS
Related Content
Advertisement
Visualization of pulmonary hypertension | Image Credit: © Thirawat - stock.adobe.com
June 30th 2025

Pulmonary Hypertension Associated With Increased Risk of Progression in Patients With Myeloproliferative Neoplasms

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Streptococcus Pneumoniae Bacteria
June 30th 2025

21-Valent Pneumococcal Conjugate Vaccine Exhibits Consistent Safety and Immunogenicity Across Manufacturing Lots

Luke Halpern, Assistant Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Bone marrow fibrosis visualization | Image Credit: © LimeSky - stock.adobe.com
June 30th 2025

INCB057643 in Combination with Ruxolitinib Improves Symptoms in Patients With Myelofibrosis

Alexandra Gerlach, Associate Editor
Woman with dry mouth -- Image credit: Rafael Ben-Ari | stock.adobe.com
June 28th 2025

Help Patients Prevent and Treat Dry Mouth

Jennifer Gershman, PharmD, CPh, PACS
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.